Literature DB >> 21437171

Duodenal somatostatinoma: a case report and review.

Jung A Kim1, Won-Ho Choi, Chul Nam Kim, Young Soo Moon, Sun Hee Chang, Hye Ran Lee.   

Abstract

Somatostatinomas are rare functioning carcinoid tumors that usually arise in the pancreas and duodenum. They are seldom associated with typical clinical symptoms; their diagnosis is confirmed only by histological and immunohistochemical studies and the presence of specific hormones. Two distinct clinicopathological forms of somatostatinoma exist: duodenal and pancreatic somatostatinomas. Clinically, compared to pancreatic somatostatinomas, duodenal somatostatinomas are more often associated with nonspecific symptoms and neurofibromatosis, but less often with somatostatinoma syndrome or metastasis. Histologically, duodenal somatostatinomas frequently have psammoma bodies in the tumor cells. We report a case of duodenal somatostatinoma in 58-year-old man with vague epigastric pain and nausea. He did not have diabetes, steatorrhea, or cholelithiasis. Abdominal computed tomography showed a 25-mm mass in the duodenum and 25-mm nodule in the liver. Endoscopic retrograde cholangiopancreatography showed a duodenal submucosal tumor. Although the endoscopic biopsies were free of malignancy, the patient subsequently underwent Whipple's operation for the duodenal mass. Examination revealed as a somatostatinoma using a special stain for somatostatin.

Entities:  

Keywords:  Carcinoid tumor; Duodenum; Somatostatinoma

Mesh:

Year:  2011        PMID: 21437171      PMCID: PMC3056248          DOI: 10.3904/kjim.2011.26.1.103

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  8 in total

1.  Carcinoid tumors of the duodenum.

Authors:  John T Mullen; Huamin Wang; James C Yao; Jeffrey H Lee; Nancy D Perrier; Peter W T Pisters; Jeffrey E Lee; Douglas B Evans
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

2.  Somatostatinoma of the ampulla of Vater.

Authors:  S K Mahajan; L A Mahajan; M A Malangoni; S Jain
Journal:  Gastrointest Endosc       Date:  1996-11       Impact factor: 9.427

3.  Periampullary pancreatic somatostatinoma.

Authors:  Michael G House; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

Review 4.  Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.

Authors:  K Martin Hoffmann; Masayuki Furukawa; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-10       Impact factor: 3.043

Review 5.  Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis.

Authors:  S Tanaka; S Yamasaki; H Matsushita; Y Ozawa; A Kurosaki; K Takeuchi; Y Hoshihara; T Doi; G Watanabe; K Kawaminami
Journal:  Pathol Int       Date:  2000-02       Impact factor: 2.534

6.  Somatostatinoma syndrome. Biochemical, morphologic and clinical features.

Authors:  G J Krejs; L Orci; J M Conlon; M Ravazzola; G R Davis; P Raskin; S M Collins; D M McCarthy; D Baetens; A Rubenstein; T A Aldor; R H Unger
Journal:  N Engl J Med       Date:  1979-08-09       Impact factor: 91.245

7.  Large duodenal somatostatinoma in the third portion associated with severe glucose intolerance.

Authors:  Ryosuke Kimura; Yoshinari Hayashi; Toyo Takeuchi; Manabu Shimizu; Maki Hiratsuka; Michihiro Yoshida; Eiji Hamajima; Masaru Iwata; Masami Imoto; Hideo Hattori
Journal:  Intern Med       Date:  2004-08       Impact factor: 1.271

8.  Pancreatic somatostatinoma. Clinical features and physiological implications.

Authors:  L I Larsson; M A Hirsch; J J Holst; S Ingemansson; C Kühl; S L Jensen; G Lundqvist; J F Rehfeld; T W Schwartz
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

  8 in total
  6 in total

1.  Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors.

Authors:  Tanios Bekaii-Saab; Robert Wesolowski; Daniel H Ahn; Christina Wu; Amir Mortazavi; Maryam Lustberg; Bhuvaneswari Ramaswamy; Jeffrey Fowler; Lai Wei; Jay Overholser; Pravin T P Kaumaya
Journal:  Clin Cancer Res       Date:  2019-02-25       Impact factor: 12.531

Review 2.  Duodenal somatostatinoma presenting as obstructive jaundice with the coexistence of a gastrointestinal stromal tumour in neurofibromatosis type 1: a case with review of the literature.

Authors:  Subhanudh Thavaraputta; Suzanne Graham; Ana M Rivas Mejia; Joaquin Lado-Abeal
Journal:  BMJ Case Rep       Date:  2019-01-10

Review 3.  Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.

Authors:  Guido Rindi; Ozgur Mete; Silvia Uccella; Olca Basturk; Stefano La Rosa; Lodewijk A A Brosens; Shereen Ezzat; Wouter W de Herder; David S Klimstra; Mauro Papotti; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2022-03-16       Impact factor: 3.943

4.  Duodenal somatostatinoma: a case report and review of the literature.

Authors:  Oguz Koc; Yigit Duzkoylu; Yavuz Selim Sari; Hasan Bektas; Gungor Uzum; Vahit Tunali; Esra Pasaoglu
Journal:  J Med Case Rep       Date:  2013-04-25

5.  Gastric somatostatinoma: an extremely rare cause of upper gastrointestinal bleeding.

Authors:  Varayu Prachayakul; Pitulak Aswakul; Morakod Deesomsak; Ananya Pongpaibul
Journal:  Clin Endosc       Date:  2013-09-30

6.  Somatostatinoma of the Ampulla: An Incidental Postoperative Finding Following Colorectal Cancer Resection.

Authors:  Joshua B French; Rishi Pawa
Journal:  ACG Case Rep J       Date:  2016-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.